PMHS
Polomar Health Services, Inc. operates as a retail compounding pharmacy. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; and intends to launch PoloMeds for diabetes medications, including metformin compounds, sulfonylureas, and insulin,… Read more
PMHS (PMHS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.045x
Based on the latest financial reports, PMHS (PMHS) has a cash flow conversion efficiency ratio of -0.045x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-352.66K) by net assets ($7.77 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
PMHS - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how PMHS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
PMHS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of PMHS ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mixed Martial Arts Group Limited
NYSE MKT:MMA
|
9.175x |
|
Kothari Products Limited
NSE:KOTHARIPRO
|
-0.007x |
|
Dominion Water Reserves Corp
PINK:DOMWF
|
0.013x |
|
Medivir AB
ST:MVIR
|
N/A |
|
Humpuss Intermoda Transportasi
JK:HITS
|
0.053x |
|
Vastland Indonesia
JK:VAST
|
0.092x |
|
High Sierra Technologies Inc
PINK:HSTI
|
0.043x |
|
Hemogenyx Pharmaceuticals Plc
PINK:HOPHF
|
6.924x |
Annual Cash Flow Conversion Efficiency for PMHS (2018–2024)
The table below shows the annual cash flow conversion efficiency of PMHS from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $9.94 Million | $-1.02 Million | -0.103x | -100.37% |
| 2023-12-31 | $-13.54K | $-371.86K | 27.466x | +12631.94% |
| 2022-12-31 | $186.77K | $-40.93K | -0.219x | -111.42% |
| 2018-12-31 | $-48.59K | $-93.25K | 1.919x | -- |